Major Depressive Disorder and Stroke Risks: A 9-Year Follow-Up Population-Based, Matched Cohort Study

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Li, Cheng Ta ^a,b   Bai, Ya Mei ^a,b   Tu, Pei Chi ^a,b   Lee, Ying Chiao ^a   Huang, Yu Lin ^b   Chen, Tzeng Ji ^a   Chang, Wen Han ^a   Su, Tung Ping ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; VENLAFAXINE;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867322964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046818     Document Type: Article

References (32)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V, (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8: 355-369.
2. Horner RD (1998) The high cost of stroke to society, the family, and the patient. Pharmacotherapy 18: 87S-93S; discussion 85S-86S.
3. Mancia G, (2004) Prevention and treatment of stroke in patients with hypertension. Clin Ther 26: 631-648.
4. Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, et al. (1999) Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 30: 736-743.
5. Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, et al. (2002) Stroke prevention: management of modifiable vascular risk factors. J Neurol 249: 507-517.
6. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K, (1987) Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257: 949-952.
7. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 346: 1647-1653.
8. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, et al. (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289: 2363-2369.
9. Dong JY, Zhang YH, Tong J, Qin LQ, (2012) Depression and risk of stroke: a meta-analysis of prospective studies. Stroke 43: 32-37.
10. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB, (2011) Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306: 1241-1249.
11. Jonas BS, Mussolino ME, (2000) Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 62: 463-471.
12. Colantonio A, Kasi SV, Ostfeld AM, (1992) Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. Am J Epidemiol 136: 884-894.
13. Lee HC, Lin HC, Tsai SY, (2008) Severely depressed young patients have over five times increased risk for stroke: a 5-year follow-up study. Biol Psychiatry 64: 912-915.
14. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, et al. (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63: 1358-1367.
15. Burns MM, Greenberg DA, (2010) Antidepressants in the treatment of stroke. Expert Rev Neurother 10: 1237-1241.
16. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC, (2008) Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother 42: 177-184.
17. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, et al. (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 169: 2128-2139.
18. Patten SB, (2008) Confounding by severity and indication in observational studies of antidepressant effectiveness. Can J Clin Pharmacol 15: e367-371.
19. Ramasubbu R, (2004) Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. J Clin Psychiatry 65: 1642-1653.
20. Scalco AZ, Scalco MZ, Azul JB, Lotufo Neto F, (2005) Hypertension and depression. Clinics (Sao Paulo) 60: 241-250.
21. Skilton MR, Moulin P, Terra JL, Bonnet F, (2007) Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 62: 1251-1257.
22. National Health Insurance Research Database T (2007).
23. Li CT, Bai YM, Huang YL, Chen YS, Chen TJ, et al. (2012) Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry 200: 45-51.
24. Maurer-Spurej E, Pittendreigh C, Solomons K, (2004) The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 91: 119-128.
25. Baron RM, Kenny DA, (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51: 1173-1182.
26. Wu CS, Wang SC, Cheng YC, Gau SS, (2011) Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry 168: 511-521.
27. Suslow T, Konrad C, Kugel H, Rumstadt D, Zwitserlood P, et al. (2010) Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol Psychiatry 67: 155-160.
28. Drevets WC, (2000) Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813-829.
29. Mello AF, Mello MF, Carpenter LL, Price LH, (2003) Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 25: 231-238.
30. Hashimoto K, Makino S, Hirasawa R, Takao T, Sugawara M, et al. (1989) Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension. Endocrinology 125: 1161-1167.
31. Laragh JH, (1973) The renin axis in causation, prognosis and treatment of hypertensive disease. Trans Stud Coll Physicians Phila 41: 131-140.
32. Beydoun MA, Wang Y, (2010) Pathways linking socioeconomic status to obesity through depression and lifestyle factors among young US adults. J Affect Disord 123: 52-63.